0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Implementation of a new health information technology for the management of cancer chemotherapies

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Cancer chemotherapy drugs are classified as high-risk molecules. Safety of the cancer chemotherapy process is often achieved with the implementation of a health information technology to each step or to the entire process. However, computerisation could lead to the emergence of new unintended medication errors. The aim of the study was to evaluate the impact of new software designed for the management of anticancer chemotherapies.

          Method

          The cartography of the process and the failure modes, effects and criticality analysis were performed by a multidisciplinary team. Criticality indexes were calculated considering or not the implementation of the commercial software (CytoWeb). Quality and satisfactory indicators were measured before the implementation and during the use of the software.

          Results

          Our results demonstrated the complexity of the cancer chemotherapy process in the hospital. Risk analysis highlighted the positive impact of CytoWeb on the process safety but pointed out some steps that were not positively influenced by the software. Although a decrease of 38.6% of error rate was observed with the electronic system, new unintended medication errors emerged. These errors were due to inadequate use of the software (encoding of the wrong drug, the wrong dose, the wrong patient parameters or lab results and lack of prescriber adherence). Our satisfaction survey showed that the hospital pharmacists and doctors were less satisfied by the software than the nurses, mostly in terms of task achievement and time saving. Survey’s results highlighted some weaknesses in the user training and in the collaboration between the medical staff.

          Conclusions

          Our work showed the emergence of unintended medication errors linked to computerisation that were due to an inadequate use of the software. Other issues were highlighted such as the lack of collaboration between the medical staff, the lack of prescriber implication and weaknesses in the user training or in the information related to CytoWeb.

          Related collections

          Author and article information

          Journal
          Eur J Hosp Pharm
          Eur J Hosp Pharm
          ejhpharm
          ejhp
          European Journal of Hospital Pharmacy
          BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
          2047-9956
          2047-9964
          September 2018
          9 May 2017
          : 25
          : 5
          : 281-285
          Affiliations
          [1 ] departmentDepartment of Pharmacy , Erasme Hospital, 808 Route de Lennik , Brussels, Belgium
          [2 ] departmentDepartment of Gastro-enterology , Erasme Hospital, 808 Route de Lennik , Brussels, Belgium
          Author notes
          [Correspondence to ] Youssef Jaadar, Department of Pharmacy, Erasme Hospital, 808 Route de Lennik, B-1070 Brussels, Belgium; youssef.jaadar@ 123456erasme.ulb.ac.be

          EAHP Statement 5: Patient Safety and Quality Assurance.

          Article
          PMC6452405 PMC6452405 6452405 ejhpharm-2016-001135
          10.1136/ejhpharm-2016-001135
          6452405
          31157040
          © European Association of Hospital Pharmacists (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
          Categories
          Original Article
          2344

          Comments

          Comment on this article